From the announcement, it seems we won't hear anything further until September. Invion won't be needing more cash until they are ready for pre-clinical research. Pre-clinical research take on average 1.5 years at an average cost of $122 million USD.
Just how cashed up are the Cho Group?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.004(4.17%) |
Mkt cap ! $8.541M | |||
| Open | High | Low | Value | Volume |
| 9.7¢ | 10.0¢ | 9.6¢ | $6.613K | 66.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 75887 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 294638 | 3 |
View Market Depth
| Last trade - 15.14pm 30/07/2025 (20 minute delay) ? |
| IVX (ASX) Chart |